Skip to content

Genomics vs HaystackAnalytics

Genomics logo

Genomics

Transforming health, healthcare and drug discovery and development through the power of genomics

184 employees · est. 2014 · Oxford, United Kingdom

VS
HaystackAnalytics logo

HaystackAnalytics

Recent Innovation: infexnᵀᴹ - A Universal Infectious Disease Test

210 employees · est. 2018 · Mumbai, India

Genomics is the older company (2014 vs 2018); HaystackAnalytics is the larger of the two.

Side-by-Side Comparison

Genomics HaystackAnalytics
Founded
2014 older 2018
Headquarters
Oxford, United Kingdom Mumbai, India
Employees
184 210 larger
Industry
Biopharma, Biotechnology, Health Care Health Care
Funding Stage
Not tracked yet Non Equity Assistance
Total Funding
$110.30M Not tracked yet
Funding Rounds
7 1
Services
Genomic Risk Prediction, AI-driven Genomic Analysis, Disease Stratification, Drug Discovery Acceleration, Biomarker Identification Universal Infectious Diseases Test, Rapid Pathogen Identification, NGS-based Diagnostics
Target Customers
Pharmacists, Healthcare Providers, Employers, Life Sciences Companies, Research Institutions Clinicians, Hospitals, Medical Laboratories
Taxonomy
Genomic PreventionPersonalised MedicineStatistical GeneticsBioinformaticsGenetic Data AnalysisDisease Risk Assessment +9 GenomicsInfectious DiseasesDiagnosticsGenomic TestingMachine Learning In HealthcareHealthcare Innovation +8
Website
genomics.com haystackanalytics.in
Genomics logo

About Genomics

Genomics is a pioneering TechBio company transforming health and healthcare through the power of genomics since its founding in 2014. Established by four renowned geneticists from the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean, the company is at the forefro...

HaystackAnalytics logo

About HaystackAnalytics

HaystackAnalytics, founded in 2018 and headquartered in India, is a dynamic player in the Health Care industry, focused on advancing genomics technology. The company’s latest innovation, infexnᵀᴹ, is a universal infectious disease test aimed at empowering healthcare professionals through precise and...

Also comparing in this category

Comparing more than these two?

Get Genomics, HaystackAnalytics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Genomics compare?

A PDF of Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Genomics was founded in 2014, based in Oxford, United Kingdom, with 184 employees. Genomics is a pioneering TechBio company transforming health and healthcare through the power of genomics since its founding in 2014. Established by four renowned geneticists from the University of Ox. HaystackAnalytics was founded in 2018, based in Mumbai, India, with 210 employees. HaystackAnalytics, founded in 2018 and headquartered in India, is a dynamic player in the Health Care industry, focused on advancing genomics technology. The company’s latest innovation, infexnᵀᴹ, is.
Genomics has raised $110.30M and HaystackAnalytics no disclosed funding. Latest stage: HaystackAnalytics Non Equity Assistance.
Both work in Health Care and list healthcare innovation among their focus areas.

Compare Genomics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genomics on 15 Jun 2026, and HaystackAnalytics on 16 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout